Sign in
CompletedNo phase

Telehealth-Delivered Gut-Directed Hypnotherapy for Managing GI Health

Key facts

Who runs it
University of Central Florida
Where
Orlando, United StatesSee the site
Trial code
Status
Completed
People taking part
11 people enrolled
Started
19 Mar 2025
Ended
30 Oct 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Nonspecific Hypnotherapy for Relaxation
  • Gut-Directed Hypnotherapy (GDH)
  • 3-month Follow-Up
Record updated
4 November 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • 18 years or older
  • Self reported gastrointestinal symptoms consistent with disorders of gut-brain interaction
  • English speaking
  • Willingness to participate in all hypnotherapy sessions \& complete all pre- and post-session surveys

Who cannot take part

  • Individuals with active or a history of severe mental illness (e.g. active psychosis, dissociative disorders)
  • Under 18 years
  • Pregnant women
  • Prisoners
  • Children
  • A hypnotic susceptibility score in the low range (SHSS; total = 0-3)

Where in United States

  • University of Central FloridaOrlando, United States

About the trial

What the trial wants to find out

This study aims to evaluate the specific and non-specific effects of hypnotherapy and to evaluate the efficacy of group-format gut-directed hypnotherapy (GDH) delivered via telehealth for managing gastrointestinal health.

The 2 groups in the trial

  • Group 1Existing treatment, for comparison

    Total enrollment time in the study will be 4 months. Participants will be divided into two groups of ten, and treatment will be provided in two 14-day intervention phases with one 3-month follow-up . One phase will include nonspecific hypnotherapy for relaxation, and one phase will include Gut-Directed Hypnotherapy (GDH) presented in a counterbalanced order depending on random assignment. Treatment conditions will be presented in a counterbalanced order depending on random assignment Hypnotherapy sessions will take place via Zoom sessions. There will be 4 sessions within each fourteen-day phase. Outcomes will be assessed through pre- and post-phase surveys, along with pre-and post-session surveys and one 3-month follow-up after completion of the two intervention phases.

    Treatment: Nonspecific Hypnotherapy for Relaxation, Gut-Directed Hypnotherapy (GDH), and 3-month Follow-Up

  • Group 2Existing treatment, for comparison

    Total enrollment time in the study will be 4 months. Participants will be divided into two groups of ten, and treatment will be provided in two 14-day intervention phases with one 3-month follow-up . One phase will include nonspecific hypnotherapy for relaxation, and one phase will include Gut-Directed Hypnotherapy (GDH) presented in a counterbalanced order depending on random assignment. Treatment conditions will be presented in a counterbalanced order depending on random assignment Hypnotherapy sessions will take place via Zoom sessions. There will be 4 sessions within each fourteen-day phase. Outcomes will be assessed through pre- and post-phase surveys, along with pre-and post-session surveys and one 3-month follow-up after completion of the two intervention phases.

    Treatment: Nonspecific Hypnotherapy for Relaxation, Gut-Directed Hypnotherapy (GDH), and 3-month Follow-Up

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
The Use of Telehealth-Delivered Gut-Directed Hypnotherapy for Managing Gastrointestinal Health
Record updated
4 November 2025